CSIMarket
 


Revolution Medicines Inc   (RVMD)
Other Ticker:  
 
 

RVMD's EPS Net Growth by Quarter and Year

Revolution Medicines Inc 's EPS Net results by quarter and year




RVMD EPS Net (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -0.56 -0.71 -0.51
III Quarter September -0.99 -0.87 -0.72 -0.42
II Quarter June -0.92 -0.82 -0.60 -0.46
I Quarter March -0.72 -0.78 -0.53 -0.74
FY   -2.63 -3.03 -2.56 -2.13



RVMD EPS Net third quarter 2023 Y/Y Growth Comment
Revolution Medicines Inc in the third quarter 2023 recorded EPS net loss of $ -0.99 .

According to the results reported in the third quarter 2023, Revolution Medicines Inc achieved the best EPS Net growth in Biotechnology & Pharmaceuticals industry. While Revolution Medicines Inc ' s EPS Net no change of % ranks overall at the positon no. in the third quarter 2023.




RVMD EPS Net ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Revolution Medicines Inc 's third quarter 2023 EPS Net $ -0.99 RVMD's Income Statement
Revolution Medicines Inc 's third quarter 2022 EPS Net $ -0.87 Quarterly RVMD's Income Statement
New: More RVMD's historic EPS Net Growth >>


RVMD EPS Net (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Revolution Medicines Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RVMD's III. Quarter Q/Q EPS Net Comment
Current EPS net loss of -0.99 by Revolution Medicines Inc look even more unfavourable compare to the -0.92 in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Revolution Medicines Inc achieved highest sequential EPS Net growth. While Revolution Medicines Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RVMD's III. Quarter Q/Q EPS Net Comment
III. Quarter 2023 results of -0.99 by Revolution Medicines Inc appear even less good compare to the -0.92 in the second quarter.

Within Biotechnology & Pharmaceuticals industry Revolution Medicines Inc achieved highest sequential EPS Net growth. While Revolution Medicines Inc 's EPS Net growth quarter on quarter, overall rank is .


Revolution Medicines Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative EPS Net 12 Months Ending $ -3.19 $ -3.07 $ -2.97 $ -3.03 $ -3.18
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Revolution Medicines Inc ' has realized cumulative trailing twelve months EPS net loss of $ -3 in the Sep 30 2023 period.
The business is getting worse as the cumulative EPS net loss is inflating from $ -3.07 in the twelve months ending a quarter before and $ -3.0331017625294 for the twelve months ending in the quarter Sep 30 2022 Madison F. Davis told.

Revolution Medicines Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Revolution Medicines Inc ' has realized cumulative trailing twelve months EPS net loss of $ -3 in the Sep 30 2023 period.
The situation is getting worse as the cumulative EPS net loss is inflating from $ -3.07 for the period from Jun 30 2023 to Sep 30 2022 and $ -3.0331017625294 for the twelve months ending in the quarter a year ago.

Revolution Medicines Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Biotechnology & Pharmaceuticals Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
RVMD's EPS Net Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for RVMD's Competitors
EPS Net Growth for Revolution Medicines Inc 's Suppliers
EPS Net Growth for RVMD's Customers

You may also want to know
RVMD's Annual Growth Rates RVMD's Profitability Ratios RVMD's Asset Turnover Ratio RVMD's Dividend Growth
RVMD's Roe RVMD's Valuation Ratios RVMD's Financial Strength Ratios RVMD's Dividend Payout Ratio
RVMD's Roa RVMD's Inventory Turnover Ratio RVMD's Growth Rates RVMD's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep 30 2023
Bristol myers Squibb Company24.00%$ 24.000 
Progyny Inc 23.08%$ 23.077 
Gilead Sciences Inc 21.83%$ 21.831 
Dexcom Inc 20.83%$ 20.833 
Neurocrine Biosciences Inc 18.84%$ 18.841 
Envoy Medical Inc 18.18%$ 18.182 
Idexx Laboratories Inc17.67%$ 17.674 
Edwards Lifesciences Corporation14.55%$ 14.545 
Zoetis Inc 14.16%$ 14.159 
Ensign Group Inc12.12%$ 12.121 
Vertex Pharmaceuticals Inc10.58%$ 10.585 
United Therapeutics Corporation9.57%$ 9.572 
Carlisle Companies Incorporated9.52%$ 9.524 
Iqvia Holdings Inc 9.40%$ 9.396 
Medpace Holdings Inc 8.29%$ 8.293 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com